TissueTech

12 articles about TissueTech

• Ted Davis to Succeed Amy Tseng as President and CEO of TissueTech

  1/27/2022

  TissueTech, Inc., a pioneer in the clinical application of cryopreserved human birth tissue products to treat ocular surface disease and disorders, chronic wounds, and musculoskeletal conditions, has named Ted Davis as the company’s new president and CEO.

• TissueTech Furthers Late-Phase Research of Biologic Candidate TTAX01 to Treat Advanced Wagner Grade 3-4 Diabetic Foot Ulcers

  11/12/2020

  Phase 3 confirmatory trials evaluate the safety and efficacy of using cryopreserved umbilical cord to achieve complete wound closure of non-healing DFUs with high-risk factors

• Amniox Announces Initiation for First of Two Phase 3 Clinical Trials of Cryopreserved Umbilical Cord TTAX01 Allograft to Treat Complex Wagner Grade 3-4 Diabetic Foot Ulcers

  6/30/2020

  Company's first biologic license application candidate TTAX01 to enter Investigational New Drug Phase 3 Trials for Diabetic Foot Ulcer indication as first biologic product to seek FDA approval for complex Wagner Grade 3 and 4 DFUs

• Latest Complex Wound Care Research from Amniox Highlighted at SAWC Fall 2019 Meeting

  10/28/2019

  Scientific Posters Showcase Successful Treatment of Complex Wounds using NEOX® Cryopreserved Umbilical Cord Allograft to Accelerate Healing and Restore Function

• TissueTech Expands its Clinical Program with Medidata’s End-to-end Unified Platform

  7/2/2019

  Medidata Rave Clinical Cloud™ to help spearhead the company’s biologics transformation

• TissueTech, Inc. Awarded Patent for Compositions of Morselized Umbilical Cord and Amniotic Membrane

  5/14/2018

  TissueTech Inc., the pioneer in the development and clinical application of regenerative amniotic tissue-based products, announced that it has been awarded patent 9,808,491 by the U.S. Patent Trademark Office.

• TissueTech Appoints Dr. Frank Young Executive Vice President of Regulatory Affairs

  5/10/2018

  TissueTech Inc., pioneers of the development and clinical application of amniotic tissue-based products, announced today the appointment of Dr. Frank Young as Executive Vice President of Regulatory Affairs.

• TissueTech, Inc. Names Adrian Roji Chief Commercial Officer

  3/6/2018

  New Chief Commercial Officer brings broad experience in regenerative medicine

• AMNIOX Medical Awarded Premier Agreement for Regenerative Medicine Products

  12/11/2017

  Dec. 11, 2017 15:19 UTC AMNIOX Medical Awarded Premier Agreement for Regenerative Medicine Products Offers Access to Amniotic Membrane Products to Premier Members ATLANTA--( BUSINESS WIRE )-- AMNIOX Medical, Inc., a TissueTech, Inc. company, has been awarded a group purchasing agreement for Regenerative Skin Grafting Products with Premier. Effective January 1, 2018, the new agreement allows Premier members, at the

• Bio-Tissue Announces Study that Demonstrates Cryopreserved Amniotic Membrane Graft Reduces Recurrence After Pterygium Surgery

  11/27/2017

  In this retrospective review, 556 eyes representing 535 patients, who had pterygium excision (527 primary, 29 recurrent) were treated with adjunctive cryopreserved amniotic membrane.

• TissueTech Awarded Four Patents For Proprietary Technology To Use Placental Tissue For Regenerative Medicine

  9/15/2017

• TissueTech Highlights Clinical Experience Showing In-Utero Spina Bifida Repair with NEOX Wound Allograft

  7/26/2016